Although assembly and physiological expression of gain-of-function ORF libraries remains challenging, these approaches have successfully identified, for example, kinases whose activation can maintain phosphoinositide-3-kinase (PI3K) signaling [18] and proteins whose overexpression confers sensitivity or resistance to cytotoxic and targeted cancer therapies [19–26]. Here, PIK3CA is linked to cancer.